Amgen Selects West’s Daikyo Crystal Zenith Vials

Offers break-resistant alternative to glass for complex drugs

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Amgen has selected West’s Daikyo Crystal Zenith (CZ) vials, in conjunction with West FluroTec stoppers, to contain its FDA-approved therapy IMLYGIC (talimogene laherparepvec), indicated for nodal lesions in patients with melanoma. CZ vials are manufactured from a cyclic olefin polymer and offer a break-resistant, high-performance alternative to glass for complex drugs.   The CZ container closure system also includes a West FluroTec stopper, which provides a barr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters